Form 8-K - Current report:
SEC Accession No. 0001193125-20-227105
Filing Date
2020-08-21
Accepted
2020-08-21 17:07:54
Documents
12
Period of Report
2020-08-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d50789d8k.htm   iXBRL 8-K 25661
  Complete submission text file 0001193125-20-227105.txt   132936

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ck0000711377-20200817.xsd EX-101.SCH 2744
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0000711377-20200817_lab.xml EX-101.LAB 15301
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0000711377-20200817_pre.xml EX-101.PRE 9580
5 EXTRACTED XBRL INSTANCE DOCUMENT d50789d8k_htm.xml XML 3102
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 201124117
SIC: 2835 In Vitro & In Vivo Diagnostic Substances